Alzheimer's Foundation of America
Select text size: a | a | a

Media Center

Press Releases


Stigma and Denial Delay Diagnosis of Alzheimer's Disease
By More Than Two Years on Average, According to New Nationwide Survey

“Serious and Unnecessary Setback” Can Rob Caregivers and People with Alzheimer's Disease
of Support Services and Treatment

New York, NY — Concern about stigma and denial of symptoms can delay a diagnosis of Alzheimer's disease by more than two years (28.7 months) on average after symptoms appear, according to a new survey from the Alzheimer's Foundation of America (AFA). When people with Alzheimer's disease are concerned about stigma, a diagnosis of Alzheimer's disease occurred on average 3.5 years (40.1 months) after symptoms appear. When caregivers are concerned about stigma, delay of diagnosis is even more severe, averaging 6 years (71.4 months). The survey was conducted by Harris Interactive ® on behalf of AFA, a national nonprofit organization providing care and services to individuals with Alzheimer's disease and related dementias, and their families.

“Any delay in diagnosis is a setback for people with Alzheimer's disease and their caregivers – and a delay of two years or more is a serious and unnecessary setback,” said Eric J. Hall, chief executive officer of the Alzheimer's Foundation of America. “While facing Alzheimer's disease is never easy, getting a diagnosis is an essential step to managing and treating the disease. Living with this in silence can isolate people with Alzheimer's disease and their caregivers, leaving them without critical support, resources, and proper treatment. We encourage everyone touched by Alzheimer's disease to reach out for support – help is out there.”

Survey results also reveal a distinct generation gap between caregivers of parents and caregivers of spouses with Alzheimer's disease. Caregivers of parents are significantly more likely than caregivers of spouses to say they now have less time for themselves (74% vs. 56%) and have felt abandoned by family (34% vs. 14%). C aregivers of spouses confide in significantly fewer sources of support than caregivers of parents (2.7 vs. 3.3 on average), and are significantly less likely to say they would like more help (52% vs. 77%). In addition, caregivers of spouses (33%) are significantly more likely than caregivers of parents (12%) to indicate that their own denial was an obstacle to diagnosis.

Many sibling relationships suffer under the stress of caring for a parent with Alzheimer's disease and the division of caregiving responsibilities. More than half of caregivers of parents, with siblings (60%), report that they are the only one of their siblings responsible for their parent's care. Many of these respondents report that relationships with siblings deteriorated after a parent was diagnosed (86% of siblings were somewhat or very close prior to diagnosis vs. 75% post-diagnosis).

Sixty-nine percent of caregivers surveyed report that they want more help from family and friends. Caregivers indicate that more help in certain areas could ease the caregiving strain, most notably assistance with day-to-day caregiving activities (20%), more financial support (16%), more emotional support (15%) and more time for themselves (13%). Caregivers of parents are significantly more likely than caregivers of spouses to feel comfortable talking about the condition with all of the people in their life (80% vs. 64%). Caregivers overall are most likely to confide in friends (58%), physicians/healthcare professionals (41%), children (38%), spouses (35%), and siblings (33%).

Lack of knowledge about the disease is a barrier to diagnosis for two in five caregivers surveyed (40%), suggesting that more education is needed. While the majority (92%) of caregivers report that they are aware of medications that may slow the progression of symptoms, only half (51%) of caregivers surveyed are aware of the opportunity for combination therapy.

“If you notice memory problems or any other possible warning signs, such as agitation, restlessness, disorientation, or difficulty performing regular tasks, make an appointment with your doctor,” said Beth Safirstein, M.D., co-president/medical director and practicing physician at the MD Clinical/MD Clinical Trials Foundation, Inc., Hallandale Beach, FL. “Diagnosis and treatment are essential because there are treatments available, including combination therapy, that have shown to potentially help maintain a person's ability to think clearly and perform everyday tasks for a longer period of time than if left untreated.”

Remarkably, many caregivers who mentioned fear of stigma and/or denial as a reason for delay in diagnosis appear to have largely overcome their fear and are more likely than those who did not struggle with stigma and denial to say they are extremely or very knowledgeable about Alzheimer's disease (72% vs. 59%).

Moreover, the majority of caregivers surveyed report finding new, positive qualities in themselves during the process of caregiving: roughly two-thirds (64%) of caregivers report they have become a more compassionate person since caring for a loved one with Alzheimer's. Additionally, 76 percent of caregivers state they have learned that they are stronger than they thought since caring for someone with the disease.

Additional key survey findings can be found at .

About the Survey
The I CAN: Investigating Caregivers' Attitudes and Needs survey examined the perceptions and feelings of caregivers of people with Alzheimer's disease. The survey is based on interviews with a nationwide cross section of 539 U.S. adults (aged 18+) who are caregivers – currently caring for a loved one with Alzheimer's disease – conducted online within the United States by Harris Interactive from January 30 to February 8, 2006, for the Alzheimer's Foundation of America (AFA) and sponsored by Forest Pharmaceuticals, Inc. 1

About Alzheimer's Disease
Alzheimer's disease is a progressive, degenerative disorder that attacks the brain's nerve cells, resulting in loss of memory, thinking and language skills, and behavioral changes. An estimated one in ten persons over age 65 and nearly half of those 85 or older have Alzheimer's disease. Alzheimer's disease currently strikes approximately five million Americans; published reports project that by 2050 this number could more than triple to more than 16 million people in the United States.

About the Alzheimer's Foundation of America
The Alzheimer's Foundation of America (AFA) is a national nonprofit organization that focuses on providing optimal care to individuals with Alzheimer's disease and related illnesses, and their families. Based in New York, AFA unites hundreds of member organizations that provide hands-on support services. AFA's services include a toll-free hotline staffed by licensed social workers, educational materials, a free magazine for caregivers, a national memory screening initiative, and training for healthcare professionals. For more information, call (Toll-Free Helpline) 866-AFA-8484 or visit .

About Harris Interactive ®
Harris Interactive Inc. ( ), based in Rochester, New York, is the 13th largest and the fastest-growing market research firm in the world, most widely known for The Harris Poll ® and for its pioneering leadership in the online market research industry. Long recognized by its clients for delivering insights that enable confident business decisions, the company blends the science of innovative research with the art of strategic consulting to deliver knowledge that leads to measurable and enduring value.

Harris Interactive serves clients worldwide through its United States, Europe ( and Asia offices, its wholly-owned subsidiary Novatris in Paris, France (, and through an independent global network of affiliate market research companies.

1 The data were weighted to represent the general population of U.S. Alzheimer's disease adult caregivers with respect to age, gender, education, income, region and propensity to be online. The weighting parameters were derived through previous research conducted by Harris Interactive, as well as from statistics generated by the Current Population Survey. In theory, with probability samples of this size, one could say with 95 percent certainty that the overall results have a sampling error of plus or minus 4 percentage points. Sampling error for the sub-samples of caregivers of parents (310), caregivers of parents with siblings (250), caregivers of spouses (138), those who mentioned fear of stigma and denial as a reason for a delay in diagnosis (279) and those who did not mention fear of stigma or denial as a reason for a delay in diagnosis (260) is higher and varies. This online sample is not a probability sample.

Contact: Carol Steinberg
Phone: 866-AFA-8484



Home  |  AFA Network  |  About   |  Contact  |  Privacy Statement

©2014 Alzheimer's Foundation of America. All rights reserved. Page Last Updated: June 5, 2014